Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Canoll

Showing results (161-170 of 233) with videos related to

Pageof 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2019
Myosin IIA suppresses glioblastoma development in a mechanically sensitive mannerHannah S Picariello, Rajappa S Kenchappa, Vandana Rai, et al.
Nature Communications|September 2, 2021
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastomaTrang T T Nguyen, Enyuan Shang, Chang Shu, et al.
Cell Reports|March 12, 2020
Transferrin Receptor Is a Specific Ferroptosis MarkerHuizhong Feng, Kenji Schorpp, Jenny Jin, et al.
Journal of Neurosurgery|May 9, 2020
Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomasAndrew L A Garton, Connor J Kinslow, Ali I Rae, et al.
Cancer Research|January 7, 2014
The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progressionAdam M Sonabend, Mukesh Bansal, Paolo Guarnieri, et al.
Journal of Neuro-Oncology|December 22, 2017
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastomaDeborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, et al.
Cell Reports|June 22, 2022
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastomaRajappa S Kenchappa, Athanassios Dovas, Michael G Argenziano, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosisAngeliki Mela, Abby Brand, Aayushi Mahajan, et al.
Journal of Neuro-Oncology|August 14, 2019
Extent of resection and survival for oligodendroglioma: a U.S. population-based studyConnor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in GlioblastomaRajappa Kenchappa, Laszlo Radnai, Erica J Young, et al.
Pageof 24

Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2019
Myosin IIA suppresses glioblastoma development in a mechanically sensitive mannerHannah S Picariello, Rajappa S Kenchappa, Vandana Rai, et al.
Nature Communications|September 2, 2021
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastomaTrang T T Nguyen, Enyuan Shang, Chang Shu, et al.
Cell Reports|March 12, 2020
Transferrin Receptor Is a Specific Ferroptosis MarkerHuizhong Feng, Kenji Schorpp, Jenny Jin, et al.
Journal of Neurosurgery|May 9, 2020
Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomasAndrew L A Garton, Connor J Kinslow, Ali I Rae, et al.
Cancer Research|January 7, 2014
The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progressionAdam M Sonabend, Mukesh Bansal, Paolo Guarnieri, et al.
Journal of Neuro-Oncology|December 22, 2017
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastomaDeborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, et al.
Cell Reports|June 22, 2022
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastomaRajappa S Kenchappa, Athanassios Dovas, Michael G Argenziano, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosisAngeliki Mela, Abby Brand, Aayushi Mahajan, et al.
Journal of Neuro-Oncology|August 14, 2019
Extent of resection and survival for oligodendroglioma: a U.S. population-based studyConnor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in GlioblastomaRajappa Kenchappa, Laszlo Radnai, Erica J Young, et al.
Pageof 24